| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/11/1994 | US5277907 Regulation of the immune system |
| 01/11/1994 | CA1326022C 6-oxoprostaglandin-e derivatives, method for their manufacture and their use as pharmaceuticals |
| 01/11/1994 | CA1326017C Ribofuranuronic acid derivatives |
| 01/06/1994 | WO1994000555A2 Compositions for the inhibition of protein hormone formation and uses thereof |
| 01/06/1994 | WO1994000491A1 INTERLEUKIN-1β DELETION MUTANT |
| 01/06/1994 | WO1994000486A1 Neuropeptide y antagonists |
| 01/06/1994 | WO1994000480A1 Steroidal glycosides for treating hypercholesterolemia |
| 01/06/1994 | WO1994000453A1 Purinone antianginal agents |
| 01/06/1994 | WO1994000444A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 01/06/1994 | WO1994000441A1 N(hetero)-aryl-n(hetero)-tetralin-alkyl-piperazine having serotoninergic, dopaminergic and adrenergic activity |
| 01/06/1994 | WO1994000440A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 01/06/1994 | WO1994000434A1 Novel nicotinic acid esters |
| 01/06/1994 | WO1994000124A1 Glycine receptor antagonists and the use thereof |
| 01/06/1994 | WO1994000120A1 Chemical compounds |
| 01/06/1994 | WO1994000095A2 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | WO1992009573A3 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/06/1994 | CA2139127A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 01/06/1994 | CA2139104A1 Steroidal glycosides for treating hypercholesterolemia |
| 01/06/1994 | CA2138374A1 Neuropeptide y antagonists |
| 01/06/1994 | CA2138124A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | CA2137685A1 N(hetero)-aryl-n-(hetero)-tetralin-alkyl-piperazine having serotoninergic, dopaminergic and adrenergic activity |
| 01/05/1994 | EP0577394A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 01/05/1994 | EP0577151A1 Use of GHL-Cu as antiinflammatory agent |
| 01/05/1994 | EP0577025A2 Angiotensin-II-receptorantagonist for the treatment and prophylaxis of coronary heart diseases |
| 01/05/1994 | EP0577024A1 3,4,5 substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
| 01/05/1994 | EP0577023A2 Angiotensin-II receptor-antagonists for the treatment of arrhythmices |
| 01/05/1994 | EP0576915A2 cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders |
| 01/05/1994 | EP0576914A2 14-Deoxy-14-alpha-cardenolides 3-beta-thioderivatives and pharmaceutical composition comprising same for treating cardiovascular disorders |
| 01/05/1994 | EP0576913A2 Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders |
| 01/05/1994 | EP0576898A2 Linear peptides |
| 01/05/1994 | EP0576619A1 1,2-dithiole-3-thione derivative-based therapeutical compositions. |
| 01/05/1994 | EP0576617A1 Composition and method containing optically pure (s) metoprolol. |
| 01/05/1994 | EP0576452A1 Products containing verapamil and trandolapril. |
| 01/05/1994 | EP0576433A1 Use of lacidipine for the treatment of arteriosclerosis |
| 01/05/1994 | DE4228493C1 Kurbeltrieb für einen Scheibenwischerantrieb eines Kraftfahrzeugs Crankshaft for a windshield wiper drive a motor vehicle |
| 01/05/1994 | CN1080288A Acylaminoindole derivatives |
| 01/05/1994 | CN1023404C Preparation of benzopyran derivatives |
| 01/05/1994 | CN1023402C Preparation of serotonin antagonists |
| 01/05/1994 | CN1023399C Preparation of 8-substituted-2-aminotetralines |
| 01/04/1994 | US5276207 Process for preparing 1-[/2S/-methyl -3-mercapto-propionyl]-pyrrolidine-/2S/-carboxylic acid |
| 01/04/1994 | US5276153 Antagonist of platelet activating factor for bronchodilation |
| 01/04/1994 | US5276049 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and methods of using the same |
| 01/04/1994 | US5276048 4-(1H-pyrrol-1-yl)imidazoles with angiotensin II antagonist activity |
| 01/04/1994 | US5276027 Ionotropic agents, vasodilation agents, circulation promoters, antiasthmetics, cognition activators, antidepressants and antiinflammatory agents |
| 01/04/1994 | US5275824 Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 01/02/1994 | CA2099447A1 Angiotensin ii receptor antagonists for the treatment and prophylaxis of coronary heart disease |
| 01/02/1994 | CA2099445A1 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 01/02/1994 | CA2099425A1 Angiotensin ii receptor antagonists for the treatment of disturbances in cardiac rhythm |
| 12/30/1993 | CA2099233A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 12/29/1993 | EP0576357A1 Pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 12/29/1993 | EP0576349A1 Indolizine derivatives, process of preparation and use for the preparation of aminoalkyloxybenzenesulfonylindolizine compounds with pharmaceutical activity |
| 12/29/1993 | EP0575844A2 Hydroxamic acid derivatives and pharmaceutical compositions thereof |
| 12/29/1993 | EP0575782A1 Phenyl-1,2,5-oxadiazole-carbonamide-2-oxides for the treatment of cardiovascular disorders, in particular erectile dysfunction |
| 12/29/1993 | EP0575754A1 Pyridyl-1,2,5-oxadiazol-2-oxide-carbonamides for the treatment of NO-dependent disfunctions like angina pectoris and erection disorders |
| 12/29/1993 | EP0575572A1 Stable salts of (+)-(1s,2r)-2- n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino]carbonyl]cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them |
| 12/29/1993 | EP0575557A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 12/29/1993 | EP0575464A1 Modified factor vii |
| 12/29/1993 | EP0575362A1 TETRAHYDROTHIENO(2,3-c)PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION |
| 12/29/1993 | EP0575361A1 New 1-aryl-4-piperazinyl-cyclohexanecarboxylic acid nitriles, their production and their use. |
| 12/29/1993 | CN1079898A Oxaspiro |2,5¨ octane derivative |
| 12/29/1993 | CN1023293C Controlling-release preparation |
| 12/28/1993 | US5274104 N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders |
| 12/28/1993 | US5273989 3,5-disubstituted 2-isoxazolines and isoxazoles, agents containing them and their use |
| 12/28/1993 | US5273977 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 12/27/1993 | CA2099078A1 Imidazolyl-substituted cyclohexane derivatives |
| 12/26/1993 | CA2098166A1 Hydroxamic acid derivatives |
| 12/24/1993 | CA2098982A1 Indolizine derivatives, process of preparation and use for the preparation of aminoalkoxybenzenesulphonylindolizine compounds with pharmaceutical activity |
| 12/23/1993 | WO1993025694A1 Inhibitors of ced-3 and related proteins |
| 12/23/1993 | WO1993025679A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 12/23/1993 | WO1993025667A1 D-enzyme compositions and methods of their use |
| 12/23/1993 | WO1993025581A1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors |
| 12/23/1993 | WO1993025577A2 Active component of parathyroid hypertensive factor |
| 12/23/1993 | WO1993025576A2 Peptides having platelet-derived growth factor (pdgf) activity |
| 12/23/1993 | WO1993025574A1 Inhibitors of angiotensin i chymase(s) including human heart chymase |
| 12/23/1993 | WO1993025568A2 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 12/23/1993 | WO1993025553A1 Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
| 12/23/1993 | WO1993025550A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 12/23/1993 | WO1993025547A1 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
| 12/23/1993 | WO1993025530A2 Vinyl arenas having retinoid-like activity |
| 12/23/1993 | WO1993025527A1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
| 12/23/1993 | DE4219782A1 New benzimidazol-1-yl-methyl-bi:phenyl derivs. |
| 12/23/1993 | CA2418594A1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 12/23/1993 | CA2138151A1 New polypeptides with a nmda receptor activity, nucleic acid coding for these polypeptides and their use |
| 12/23/1993 | CA2137829A1 Active component of parathyroid hypertensive factor |
| 12/23/1993 | CA2137819A1 Vinyl arenas having retinoid-like activity |
| 12/23/1993 | CA2137814A1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors |
| 12/23/1993 | CA2137367A1 Peptides having platelet-derived growth factor (pdgf) activity |
| 12/23/1993 | CA2136547A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 12/23/1993 | CA2134222A1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 12/23/1993 | CA2112360A1 Bicyclic fibrinogen antagonists |
| 12/22/1993 | EP0575069A1 Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of antithrombotic and anti-vasospastic compounds |
| 12/22/1993 | EP0574906A2 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing the same |
| 12/22/1993 | EP0574846A2 Imidazopyridines as angiotensin II antagonistes |
| 12/22/1993 | EP0574787A2 Benzimidazole derivatives as angiotensin II antagonists |
| 12/22/1993 | EP0574774A1 Substituted benzothiazolyl- and quinoxalyl methoxy-phenyl acetic acid derivatives |
| 12/22/1993 | EP0574758A1 Hydroxamic acid derivatives as collagenase inhibitors |
| 12/22/1993 | EP0574726A1 Annelated 1,2,5-oxadiozole-2 oxides and their use as pharmacological agents |
| 12/22/1993 | CN1079649A Imidazolyl-alkenoic acids |
| 12/22/1993 | CN1079648A Imidazolyl-alkenoic acids |
| 12/22/1993 | CN1023219C Substituted imidazole derivatives and their preparation and use |